Ilyang Pharm (007570)

Seoul
38,000.00
-800.00(-2.06%)
  • Volume:
    146,709
  • Bid/Ask:
    37,950.00/38,000.00
  • Day's Range:
    37,550.00 - 38,600.00

007570 Overview

Prev. Close
38,800
Day's Range
37,550 - 38,600
Revenue
343.33B
Open
38,550
52 wk Range
31,550 - 106,000
EPS
597.61
Volume
146,709
Market Cap
759.42B
Dividend (Yield)
120.00 (0.31%)
Average Vol. (3m)
261,342
P/E Ratio
64.93
Beta
-0.09
1-Year Change
14.37%
Shares Outstanding
18,205,180
Next Earnings Date
May 18, 2021
What is your sentiment on Ilyang Pharm?
or
Vote to see community's results!

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellBuyNeutralStrong Sell
Technical IndicatorsStrong SellSellNeutralNeutralStrong Sell
SummaryStrong SellSellNeutralNeutralStrong Sell

Ilyang Pharm Company Profile

Ilyang Pharm Company Profile

Employees
636

Ilyang Pharmaceutical Co Ltd is a Korea-based company principally engaged in the manufacture and distribution of pharmaceutical products. The Company mainly manufactures and sells pharmaceutical products including prostatitis agents, anti-inflammatory drugs, diabetic agents, gastritis agents, and others. The Company also produces products including nourishing tonics and health supplements, among others.

Read More
  • long for 60k
    0
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.